DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
ECM-receptor interaction	R-HSA-373711	map04512	myosmine	442649	drug-path
Ribosome	R-HSA-5368277	map03010	myosmine	442649	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	myosmine	442649	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	myosmine	442649	drug-path
Pathways in cancer	R-HSA-9824443	map05200	myosmine	442649	drug-path
Ubiquitin mediated proteolysis	R-HSA-983153	map04120	benzamil	417052	drug-path
Alzheimer's disease	R-HSA-1643685	0	benzamil	417052	drug-path
Huntington's disease	R-HSA-1643685	0	benzamil	417052	drug-path
Olfactory transduction	R-HSA-9751605	map04740	benzamil	417052	drug-path
Focal adhesion	R-HSA-354113	map04510	benzamil	417052	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	benzamil	417052	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	benzamil	417052	drug-path
Parkinson's disease	R-HSA-1643685	0	benzamil	417052	drug-path
Ribosome	R-HSA-5368277	map03010	benzamil	417052	drug-path
Small cell lung cancer	R-HSA-5619066	map05222	benzamil	417052	drug-path
Ubiquitin mediated proteolysis	R-HSA-983153	map04120	PNU-0230031	None	drug-path
Olfactory transduction	R-HSA-9751605	map04740	PNU-0230031	None	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	PNU-0230031	None	drug-path
Cell cycle	R-HSA-1640170	map04110	PNU-0230031	None	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	PNU-0230031	None	drug-path